mAbxience, a Fresenius entity, has entered a strategic collaboration with HP Inc. to develop an artificial intelligence (AI) solution designed to optimise the manufacturing of monoclonal antibodies and biosimilars. The new system includes a digital twin of the biological process
Benuvia Operations, LLC has formed a strategic partnership with Cannovation Clinical Research Partners to develop what the organisations describe as the industry’s first fully integrated manufacturing and contract research platform dedicated to Schedule I–V substances. The collaboration is designed to
Thermo Fisher Scientific Inc. has expanded its bioprocessing capabilities across Asia through the introduction of a new Bioprocess Design Center in Hyderabad, India, and enhancements to its existing centres in Incheon, Korea, and Singapore. The company said the investment supports
Polyrizon Ltd. has announced the successful completion of a major manufacturing upscaling milestone for its proprietary nasal-spray product platform based on the company’s Capture & Contain technology. The achievement marks a key step in preparing for upcoming clinical and regulatory
BioNexus Gene Lab Corp. has signed a $500 million Equity Purchase Agreement with ARC Group International Ltd. to support its precision oncology, CDMO and therapeutic development initiatives across Southeast Asia. The company said the facility provides long-term, discretionary access to
AGC Biologics has expanded its Cell Line Development Centre of Excellence through a partnership with ATUM, integrating the Leap-In Transposase expression platform into its global CDMO offering. The collaboration aims to support drug developers under pressure to reduce costs and
WuXi Biologics has signed a Memorandum of Understanding (MoU) with the Qatar Free Zones Authority (QFZ) to expand its global Contract Research, Development and Manufacturing Organization network into the Middle East. The agreement was witnessed by government representatives including H.E.
Rentschler Biopharma has entered a strategic collaboration with Coriolis Pharma to offer integrated services across the biopharmaceutical development and manufacturing process. The companies will provide clients with a unified interface and coordinated project teams to support progression from early formulation
Cellipont Bioservices has completed its ballroom-style cleanroom, which includes a 50-litre single-use bioreactor to support advanced cell therapy manufacturing. The expansion is part of the company’s investment strategy to meet demand for exosome, induced pluripotent stem cell and mesenchymal stem
eXmoor Pharma has entered a strategic collaboration with the Translational Research Office (TRO) at University College London (UCL) to accelerate the development of novel cell and gene therapies from academic research into clinical use. The partnership aims to create earlier
